La traduzione di questa pagina è sperimentale e in fase di sviluppo. Siamo lieti di ricevere vostro !

Neurones Crescita futura

Future criteri di controllo 0/6

Al momento non disponiamo di una copertura analitica sufficiente per prevedere la crescita e il fatturato di Neurones.

Informazioni chiave

n/a

Tasso di crescita degli utili

n/a

Tasso di crescita dell'EPS

IT crescita degli utili	13.9%
Tasso di crescita dei ricavi	n/a
Rendimento futuro del capitale proprio	n/a
Copertura analitica	Low
Ultimo aggiornamento	28 Jun 2024

Aggiornamenti recenti sulla crescita futura

Recent updates

Neurones S.A.'s (EPA:NRO) Stock's On An Uptrend: Are Strong Financials Guiding The Market?

Mar 09

The Neurones (EPA:NRO) Share Price Has Gained 54% And Shareholders Are Hoping For More

Feb 16

Here's Why Neurones's (EPA:NRO) Statutory Earnings Are Arguably Too Conservative

Jan 25

What Percentage Of Neurones S.A. (EPA:NRO) Shares Do Insiders Own?

Jan 11

Should Neurones S.A. (EPA:NRO) Be Part Of Your Dividend Portfolio?

Dec 28

Are Neurones S.A. (EPA:NRO) Investors Paying Above The Intrinsic Value?

Dec 15

What We Learned About Neurones' (EPA:NRO) CEO Pay

Dec 02

Investors Who Bought Neurones (EPA:NRO) Shares Five Years Ago Are Now Up 39%

Nov 17

Neurones (EPA:NRO) Is Growing Earnings But Are They A Good Guide?

Jun 30

Previsioni di crescita degli utili e dei ricavi

ENXTPA:NRO - Stime future degli analisti e dati finanziari passati (EUR Millions )
Data	Ricavi	Guadagni	Flusso di cassa libero	Liquidità dell'operazione	Avg. Numero di analisti
12/31/2024	800	50	N/A	N/A	1
12/31/2023	741	49	54	72	N/A
9/30/2023	724	49	59	74	N/A
6/30/2023	707	48	64	76	N/A
3/31/2023	686	46	54	65	N/A
12/31/2022	665	44	44	55	N/A
9/30/2022	642	43	42	51	N/A
6/30/2022	618	41	40	47	N/A
3/31/2022	599	40	49	56	N/A
12/31/2021	580	38	58	64	N/A
9/30/2021	570	37	58	65	N/A
6/30/2021	559	36	58	66	N/A
3/31/2021	542	33	59	67	N/A
12/31/2020	524	31	60	67	N/A
9/30/2020	518	30	61	69	N/A
6/30/2020	511	28	63	70	N/A
3/31/2020	510	30	58	66	N/A
12/31/2019	510	31	53	61	N/A
9/30/2019	505	30	46	53	N/A
6/30/2019	501	30	38	45	N/A
3/31/2019	495	28	31	38	N/A
12/31/2018	490	26	24	31	N/A
9/30/2018	487	26	20	28	N/A
6/30/2018	483	26	16	25	N/A
3/31/2018	484	27	15	24	N/A
12/31/2017	485	27	14	23	N/A
9/30/2017	478	27	N/A	24	N/A
6/30/2017	470	27	N/A	25	N/A
3/31/2017	459	26	N/A	23	N/A
12/31/2016	447	25	N/A	21	N/A
9/30/2016	436	24	N/A	21	N/A
6/30/2016	425	23	N/A	20	N/A
3/31/2016	412	22	N/A	25	N/A
12/31/2015	399	21	N/A	30	N/A
9/30/2015	386	21	N/A	30	N/A
6/30/2015	374	21	N/A	29	N/A
3/31/2015	364	21	N/A	29	N/A
12/31/2014	355	21	N/A	29	N/A
9/30/2014	354	20	N/A	26	N/A
6/30/2014	352	20	N/A	24	N/A
3/31/2014	347	19	N/A	22	N/A
12/31/2013	343	19	N/A	20	N/A
9/30/2013	336	18	N/A	21	N/A

Previsioni di crescita futura degli analisti

Guadagni vs tasso di risparmio: Dati insufficienti per determinare se la crescita degli utili prevista NRO è superiore al tasso di risparmio ( 1.2% ).

Guadagni vs Mercato: Dati insufficienti per determinare se si prevede che gli utili di NRO cresceranno più velocemente del mercato French

Guadagni ad alta crescita: Dati insufficienti per determinare se si prevede che gli utili di NRO cresceranno in modo significativo nei prossimi 3 anni.

Ricavi vs Mercato: Dati insufficienti per determinare se si prevede che i ricavi di NRO cresceranno più rapidamente del mercato French.

Ricavi ad alta crescita: Dati insufficienti per determinare se si prevede che i ricavi di NRO cresceranno più rapidamente di 20% all'anno.

Previsioni di crescita dell'utile per azione

Rendimento futuro del capitale proprio

ROE futuro: Dati insufficienti per determinare se il Return on Equity di NRO è previsto essere elevato tra 3 anni

Neurones Crescita futura

Future criteri di controllo 0/6

Informazioni chiave

Aggiornamenti recenti sulla crescita futura

Neurones S.A. Provides Earnings Guidance for the Year 2024

Neurones S.A. Provides Earnings Guidance for the Year 2023

Neurones S.A. Provides Earnings Guidance for the Full Year 2023

Neurones S.A. Provides Earnings Guidance for the Full Year 2023

Price target increased to €44.33

Neurones S.A. Confirms its Earnings Guidance for the Full Year 2022

Recent updates

Now 21% undervalued after recent price drop

What Neurones S.A.'s (EPA:NRO) P/E Is Not Telling You

Upcoming dividend of €1.20 per share

Neurones S.A. Provides Earnings Guidance for the Year 2024

Dividend of €1.20 announced

Returns On Capital At Neurones (EPA:NRO) Have Hit The Brakes

Now 20% overvalued after recent price rise

Full year 2023 earnings released

Slowing Rates Of Return At Neurones (EPA:NRO) Leave Little Room For Excitement

Neurones S.A. to Report Fiscal Year 2023 Results on Mar 06, 2024

Neurones S.A. Provides Earnings Guidance for the Year 2023

Now 22% undervalued after recent price drop

Now 20% undervalued after recent price drop

First half 2023 earnings released

Neurones S.A. Provides Earnings Guidance for the Full Year 2023

Upcoming dividend of €1.10 per share at 2.8% yield

If EPS Growth Is Important To You, Neurones (EPA:NRO) Presents An Opportunity

Neurones S.A. Provides Earnings Guidance for the Full Year 2023

Full year 2022 earnings released

Neurones' (EPA:NRO) Returns Have Hit A Wall

Neurones S.A. to Report Fiscal Year 2022 Results on Mar 08, 2023

Price target increased to €44.33

Less than half of directors are independent

Neurones S.A., Annual General Meeting, Jun 08, 2023

Neurones S.A. to Report First Half, 2023 Results on Sep 06, 2023

Slowing Rates Of Return At Neurones (EPA:NRO) Leave Little Room For Excitement

Does Neurones (EPA:NRO) Deserve A Spot On Your Watchlist?

Neurones S.A. Confirms its Earnings Guidance for the Full Year 2022

First half 2022 earnings released

Neurones S.A. Provides Earnings Guidance for the Year 2022

Upcoming dividend of €1.00 per share

Neurones (EPA:NRO) Will Pay A Smaller Dividend Than Last Year

Full year 2021 earnings: Revenues in line with analyst expectations

Price target increased to €41.00

Less than half of directors are independent

Full year 2021 earnings: Revenues in line with analyst expectations

Should You Be Adding Neurones (EPA:NRO) To Your Watchlist Today?

Returns At Neurones (EPA:NRO) Appear To Be Weighed Down

Returns On Capital At Neurones (EPA:NRO) Paint A Concerning Picture

Upcoming dividend of €2.00 per share

Price target increased to €32.50

Price target increased to €31.00

Is Neurones S.A. (EPA:NRO) Trading At A 25% Discount?

Full year 2020 earnings released: EPS €1.28 (vs €1.27 in FY 2019)

Some Investors May Be Worried About Neurones' (EPA:NRO) Returns On Capital

Neurones S.A.'s (EPA:NRO) Stock's On An Uptrend: Are Strong Financials Guiding The Market?

Full year 2020 earnings released

Revenue beats expectations

The Neurones (EPA:NRO) Share Price Has Gained 54% And Shareholders Are Hoping For More

New 90-day high: €25.70

Price target raised to €29.00

Here's Why Neurones's (EPA:NRO) Statutory Earnings Are Arguably Too Conservative

Price target raised to €28.25

What Percentage Of Neurones S.A. (EPA:NRO) Shares Do Insiders Own?

Should Neurones S.A. (EPA:NRO) Be Part Of Your Dividend Portfolio?

New 90-day low: €23.00

Are Neurones S.A. (EPA:NRO) Investors Paying Above The Intrinsic Value?

What We Learned About Neurones' (EPA:NRO) CEO Pay

Investors Who Bought Neurones (EPA:NRO) Shares Five Years Ago Are Now Up 39%

Analysts increase EPS estimates to €1.12

Neurones S.A. to Report Fiscal Year 2020 Results on Mar 03, 2021

First half earnings released

New 90-day high - €25.60

Neurones (EPA:NRO) Is Growing Earnings But Are They A Good Guide?

Previsioni di crescita degli utili e dei ricavi

Previsioni di crescita futura degli analisti

Previsioni di crescita dell'utile per azione

Rendimento futuro del capitale proprio

Scoprire le aziende in crescita